Genomic medicine and rare disease at FoG London 2027

Jan 27–28, 2027 London, UK ~8.3k attendees Website

54 organizations at FoG London 2027 present work in genomic medicine & rare disease: 26 NHS, government and non-profit bodies, 19 suppliers and service providers and 9 universities and research institutes. Between them they bring 94 presentations to the program. Most represented: University of Oxford, University of Edinburgh and The Institute of Cancer Research. As of Oct 29, 2026.

All 243 organizations at FoG London 2027 →

Format
Top represented
Showing 1–5 of 54 organizations
OrganizationFoG London 2027 Attendance
Universities & institutes
Collegiate research university in Oxford, England, whose Medical Sciences Division spans human genetics, population health and clinical research.
Talk
Wed Jan 27
11:30–12:00
Why Do We Sleep?
Why animals evolved to sleep, how light and body clocks time it, and how shift work and jet lag disrupt health.
Population & social genomics
Talk
Wed Jan 27
12:30–13:00
Sequence Data for Outbreak Intelligence: Gene-by-Gene Genomics and Population Annotation in Pathogen Surveillance
Why tracking bacterial outbreaks needs gene-by-gene genome comparison rather than human genetics methods, shown through an outbreak of meningococcal disease in Kent.
Talk
Wed Jan 27
14:30–15:00
Design and Translation of Next Generation Delivery Vehicles for Advanced Therapeutics
New ways to deliver advanced therapies, including pulsed and long-acting release systems, microrobots and new tools for measuring nanoparticles.
Talk
Wed Jan 27
14:30–15:00
Making AMR Diagnostics Work Where They Matter Most: Genomics, Sepsis and Sustainable Implementation
Why tests for drug-resistant infections and newborn sepsis in low- and middle-income countries depend on cost and infrastructure, and how genomics tracks spread.
Talk
Wed Jan 27
16:30–17:00
Accelerating the Development of Therapies for Rare Genetic Disease
How a transatlantic partnership brings expertise and investment to preclinical drug projects for rare genetic diseases.
Talk
Wed Jan 27
16:30–17:00
The AI Revolution After the Genome: How AI Is Inventing Genetically Enabled Medicines
How genomic discoveries, national supercomputers and self-running laboratories are letting AI design new medicines based on genetics.
Talk
Wed Jan 27
16:30–17:00
The Body Clock in Your Blood: Circadian Signals in Omics Research
How proteins and metabolites in one blood sample can reveal a person's body-clock time, and why time of day skews biomarker studies.
Talk
Wed Jan 27
17:30–18:00
Using Pathogen Genomics to Inform Vaccine Strategy and Public Health Response
How international lab data on invasive bacterial disease track post-pandemic shifts in bacterial strains and what they mean for vaccines.
Talk
Thu Jan 28
11:30–12:00
Harnessing Bacterial Competition to Prevent Disease in the Gut Microbiome
How finding the gut bacteria that best outcompete pathogens can guide the design of protective microbial mixtures.
Talk
Thu Jan 28
12:30–13:00
Deciphering Mammalian Morphogenesis - A Single-Cell Phenomic Perspective
How tracking single cells' molecules, shape and behaviour in early mammalian embryos shows how the front end is patterned and the heart starts beating.
Panel
Thu Jan 28
14:10–14:40
Is Modern Life Fighting Our Human Biology?
Whether modern food environments and inactive lifestyles clash with our evolved biology, and why genetics makes some people more prone to obesity.
with University of Cambridge, University of Leeds, Leeds Beckett University
Population & social genomics
Talk
Thu Jan 28
14:10–14:40
Multimodal Liquid Biopsy for Early Cancer Detection: From Methylation to Single-Molecule Sequencing
Why first-generation multi-cancer blood tests fall short, and how AI analysis of several features of tumour DNA in the blood could improve them.
Talk
Thu Jan 28
14:10–14:40
Quantum Computing & The Future of Genomic Data: From Single Genomes to Pangenomes
How a virus genome encoded on a quantum computer points to new ways of analysing pangenomes, reference sets built from many genomes.
Talk
Thu Jan 28
14:10–14:40
Why Endometriosis Is Not One Disease: Insights from Genetics
How large genetic studies split endometriosis into distinct subtypes, link it to ovarian and endometrial cancers and point to new treatment targets.
Workshop
Thu Jan 28
14:10–15:40
Making Sense of Multi-Omic Data: Scalable Analysis and Interpretation
Workshop Room · with EMBL, University of Surrey
Multi-omics & proteomics
Talk
Thu Jan 28
14:40–15:10
The MWS: 3 Decades of Research into the Effects of Menopausal Hormone Therapy on Women's Health
Women & Children's Health Stage
Talk
Thu Jan 28
15:10–15:40
Utilising Multi-omic Integration & Machine Learning for the Better Understanding of Disease: Painful and Painless Peripheral Neuropathy Example
How combining genetic, gene expression, protein and metabolite markers could explain why only some people with nerve damage develop lasting pain.
Panel
Thu Jan 28
15:10–15:40
Why Does Disease Spare Some of Us?
Why the same infection makes some people very ill and spares others, and how naturally resistant people could inspire new treatments.
with Imperial College London, University of Edinburgh
Population & social genomics
Talk
Thu Jan 28
16:10–16:40
Single-Cell & Spatial Multi-Omics to Decrypt Intestinal Development
How a cell-by-cell map of the developing human gut tracks its maturation and why preterm birth may impair it.
Workshop
Thu Jan 28
16:10–17:10
From Variant to Action: A Hands-On Workshop to Reimagine Variant Interpretation
Workshop Room · with University of Edinburgh, NHS, North East and Yorkshire Genomic Laboratory Hub
Genomic medicine & rare disease
Talk
Thu Jan 28
16:40–17:10
Human in vivo Perturb Seq: New Insights into Human Inflammatory Disease
How repeated tissue biopsies from treated patients, read cell by cell, reveal how drugs act on inflammatory diseases and why some stop working.
Talk
Thu Jan 28
16:40–17:10
Leveraging Big Data to Inform Cardiovascular Precision Medicine
How combining genomic, clinical and real-world patient data can identify cardiovascular disease risk and guide more targeted prevention and treatment.
Universities & institutes
Public research university in Edinburgh, Scotland, with a medical school, the Institute of Genetics and Cancer and the Roslin Institute for animal sciences.
Talk
Wed Jan 27
11:30–13:00
Interactive Session: Building Trust in AI – Identifying Bias, Data Leakage and Hidden Failure Modes
Genome Dome · with University of Surrey, The Alan Turing Institute, Queen Mary University of London +2 more
AI in drug discovery & diagnostics
Talk
Wed Jan 27
16:30–17:00
Four Nations Data Linkage in Longitudinal Research - Opportunities and Challenges
What it takes to link long-running population studies across England, Scotland, Wales and Northern Ireland into richer research datasets.
Talk
Wed Jan 27
17:00–17:30
Beyond the Majority: Rethinking Treatment for Rare Ovarian Cancer Subtypes
Why rarer ovarian cancer subtypes are understudied, and how genomic insights and newer drugs could improve their treatment.
Talk
Thu Jan 28
12:00–12:30
Using Epigenetic Signatures to Predict Ageing and Disease Risk
How DNA methylation marks can estimate ageing and disease risk, and reveal effects of pollution, smoking and vaping in large cohorts.
Talk
Thu Jan 28
12:30–13:00
Developing a Clinically Useful Blood Test for Earlier Brain Tumour Diagnosis
How a blood test using infrared light could catch brain tumours earlier, and what good diagnostic accuracy means in practice.
Talk
Thu Jan 28
14:10–14:40
3D Genome Organisation and Gene Regulation: Understanding the Non-Coding Genome
How the three-dimensional folding of chromosomes brings distant control regions into contact with genes, and what this reveals about non-coding DNA.
Panel
Thu Jan 28
15:10–15:40
Why Does Disease Spare Some of Us?
Why the same infection makes some people very ill and spares others, and how naturally resistant people could inspire new treatments.
with Imperial College London, University of Oxford
Population & social genomics
Workshop
Thu Jan 28
16:10–17:10
From Variant to Action: A Hands-On Workshop to Reimagine Variant Interpretation
Workshop Room · with NHS, University of Oxford, North East and Yorkshire Genomic Laboratory Hub
Genomic medicine & rare disease
Universities & institutes
Cancer research institute and college of the University of London, working in partnership with The Royal Marsden.
Talk
Wed Jan 27
12:30–13:00
Direct-to-Patient (DTP) Genetic Testing Pathways: Unlocking Capacity For The NHS Genomic Medicine Service and Genomic Population Health Service
How offering genetic tests directly to patients could widen access while easing pressure on NHS genomic services.
Talk
Wed Jan 27
12:30–13:00
Polygenic Risk Scores for Prostate Cancer Risk Stratification - Lessons From the BARCODE1 Study
How polygenic risk scores, which add up many small genetic effects, could better target prostate cancer screening and weigh the risk of overdiagnosis.
Talk
Wed Jan 27
14:30–15:00
MAVEs: Multiplex Assays of Functional Effect: Saying Goodbye To VUSs?
How lab assays measuring the effects of thousands of genetic variants at once could settle uncertain variants in cancer genetic testing.
Talk
Wed Jan 27
14:30–15:00
Mapping the Invasive Tumour: How Spatial Biology is Revealing Cancer's Next Move
How spatial biology, which maps cells where they sit in tissue, shows how tumour layout and support cells help cancer invade.
Talk
Wed Jan 27
15:30–16:00
Exploiting Genome Evolution in Inflammatory Bowel Disease to Prevent Colorectal Cancer
How cells with abnormal chromosome numbers spread through the inflamed colon years before visible change, flagging future cancer risk in inflammatory bowel disease.
Talk
Thu Jan 28
11:30–12:00
Integrating Circulating Tumour DNA into Treating Head and Neck Cancer
How testing tumour DNA in the blood can guide head and neck cancer treatment, both curative and palliative, and what challenges remain.
NHS & hospitals
NHS trust running St George's Hospital in Tooting, a south-west London teaching hospital with clinical genetics services.
Talk
Wed Jan 27
15:30–16:00
Beyond the Diagnostic Odyssey: What Comes After Genomic Diagnosis?
How whole-genome sequencing is diagnosing children with rare developmental disorders, and what it takes to move from diagnosis to targeted treatment.
Talk
Wed Jan 27
17:30–18:00
Genotype-Guided Antiplatelet Therapy in Acute Ischemic Stroke
Why some stroke patients resist the anti-clotting drug clopidogrel, and the evidence for and barriers to genetic testing that guides treatment.
Talk
Thu Jan 28
14:10–15:40
Behind the Result, Beyond the Report: Collaborative Case Discussions on Genomic Testing Dilemmas from Different Perspectives
Genome Dome · with Oxford University Hospitals NHS Foundation Trust
Genomic medicine & rare disease
Talk
Thu Jan 28
16:40–17:10
From Research to Reality: Ensuring Women Benefit from Innovation
How to design women's health tests and technologies that work for all women, and who risks being left behind by them.
with University Hospital Southampton NHS Foundation Trust, UCL
Universities & institutes
Public research university in Manchester, England, with a Faculty of Biology, Medicine and Health.
Talk
Wed Jan 27
17:00–17:30
From One-Size-Fits-All to Personalised Cancer Screening
How combining polygenic risk scores, family history and mammogram features could tailor cancer screening to each person's risk instead of age.
Talk
Wed Jan 27
17:30–18:00
Interoperable by Design: Building the Digital Infrastructure for Population Genomics
How to build digital systems that let genomic data move between health software and give family doctors clear guidance on results.
Talk
Thu Jan 28
14:10–14:40
Designing Imaging AI for Clinical Translation from Day One
How building medical imaging AI collaboratively, with representative data and regulatory needs in mind from the start, helps it reach the clinic.
Talk
Thu Jan 28
14:40–15:10
Decoding the Epigenome: Using Multi-Omics to Understand Cancer Cell States
How machine learning helps decode epigenetic and RNA signals in cancer cells to define cancer subtypes and understand treatment response.

Explore the full FoG London 2027 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in London. Leave your work email and we’ll be in touch.

Privacy

Download the full FoG London 2027 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find buyers in genomic medicine & rare disease

Tell us what you sell and we’ll find the people at organizations working on genomic medicine & rare disease most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Browse FoG London 2027 by

Exhibit hall

Not affiliated with or endorsed by Front Line Genomics or the Festival of Genomics. Submit a correction